Quintet Private Bank (Europe)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Quintet Private Bank (Europe)'s BMY Position: Q2 2026 in Review
Quintet Private Bank (Europe) reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $334K and leaving 37,760 shares worth $2.18M. The position accounts for 0.14% of the portfolio, ranked #48.
Quintet Private Bank (Europe) first reported a position in BMY in Q2 2022 and has held it in 15 quarters since. The position peaked at $27.2M in Q1 2023. 1,058 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Quintet Private Bank (Europe) held 37,760 shares of Bristol-Myers Squibb worth $2.18M as of Q2 2026.
- Quintet Private Bank (Europe) sold 5,818 Bristol-Myers Squibb shares in Q2 2026, an estimated $334K.
- Bristol-Myers Squibb made up 0.14% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #48 holding.
- Quintet Private Bank (Europe) first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 15 quarters since.
- Quintet Private Bank (Europe)'s Bristol-Myers Squibb position peaked at $27.2M in Q1 2023.
- 1,058 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.